Apraxia and dysarthria of speech associated with FK-506 (tacrolimus)

被引:0
|
作者
Sepúlveda, JM [1 ]
Ruíz, JJ [1 ]
González, J [1 ]
Rodríguez, M [1 ]
Núñez, N [1 ]
Gómez, SM [1 ]
机构
[1] Hosp 12 Octubre, E-28041 Madrid, Spain
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:122 / 122
页数:1
相关论文
共 50 条
  • [21] A COMPARISON OF TACROLIMUS (FK-506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION IN LIVER-TRANSPLANTATION
    BUSUTTIL, RW
    MCDIARMID, S
    KLINTMALM, GB
    GOLDSTEIN, R
    MILLER, CM
    SCHWARTZ, M
    SHAW, BW
    ROBERTS, JP
    HEBERT, MF
    ESQUIVEL, CO
    NAKAZATO, P
    WIESNER, RH
    KROM, RAF
    KALAYOGLU, M
    DALESSANDRO, AM
    MARSH, JW
    PETERS, MG
    BURDICK, J
    KLEIN, A
    LEWIS, WD
    JENKINS, R
    THISTLETHWAITE, JR
    EMOND, JC
    JUSKO, WJ
    DAMBROSIO, R
    BUELL, D
    FITZSIMMONS, WE
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (17): : 1110 - 1115
  • [22] FK-506 (Tacrolimus) therapy for an unusual SLE-like disease
    Kilian, K
    Banyai, A
    Karadi, A
    Miklos, K
    Patranyi, GG
    Paloczi, K
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) : 4130 - 4131
  • [23] COMPARISON OF TACROLIMUS (FK-506) ASSAYS - ABBOTT MEIA AND INCSTAR ELISA
    SCHLUETER, K
    SCHROEDER, T
    PESCE, A
    WARNER, A
    FIRST, MR
    CLINICAL CHEMISTRY, 1995, 41 (06) : S124 - S124
  • [24] TOXICITY OF FK-506 IN THE CYNOMOLGUS MONKEY - NONCORRELATION WITH FK-506 SERUM LEVELS
    WIJNEN, RMH
    ERICZON, BG
    TIEBOSCH, ATGM
    BEYSENS, AJ
    GROTH, CG
    KOOTSTRA, G
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3101 - 3104
  • [25] Use of tacrolimus (FK-506) in the pediatric liver transplant recipient.
    Prabhakaran, K
    Wise, B
    Lau, HT
    Schwarz, K
    Colombani, PM
    PEDIATRICS, 1998, 102 (03) : 799 - 799
  • [26] TACROLIMUS (FK-506) - A NEW THERAPEUTIC AGENT FOR SEVERE RECALCITRANT PSORIASIS
    JEGASOTHY, BV
    ACKERMAN, CD
    TODO, S
    FUNG, JJ
    ABUELMAGD, K
    STARZL, TE
    ARCHIVES OF DERMATOLOGY, 1992, 128 (06) : 781 - 785
  • [27] EARLY EXPERIENCE WITH FK-506 INDUCTION IMMUNOSUPPRESSION - SUGGESTION FOR USING ORAL FK-506
    NAKAZATO, P
    COX, K
    CONCEPCION, W
    GISH, R
    BERQUIST, W
    IMPERIAL, J
    ESQUIVEL, C
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3019 - 3020
  • [28] Tacrolimus (FK 506)
    Letko, E
    Bhol, K
    Pinar, V
    Foster, CS
    Ahmed, AR
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 83 (03) : 179 - 189
  • [29] ADVERSE-EFFECTS ASSOCIATED WITH THE USE OF FK-506
    FUNG, JJ
    ALESSIANI, M
    ABUELMAGD, K
    TODO, S
    SHAPIRO, R
    TZAKIS, A
    VANTHIEL, D
    ARMITAGE, J
    JAIN, A
    MCCAULEY, J
    SELBY, R
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3105 - 3108
  • [30] FK-506 ASSOCIATED DISORDERS IN LIVER-TRANSPLANTATION
    NAZER, H
    ALSABBAN, E
    HARFI, H
    ANTONIUS, J
    DACUNHA, AM
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1992, 7 (03) : 257 - 259